A daily pill called osimertinib (Tagrisso) is delivering far longer cancer control for adults with unresectable stage 3 EGFR-mutated non-small cell lung cancer after chemoradiation and is now ...

WASHINGTON — Reduced doses of radiation therapy and immunotherapy did not work as well as the standard chemoradiation for early-stage HPV-associated oropharyngeal cancer, in a new study. These ...

Please provide your email address to receive an email when new articles are posted on . “Interest in organ preservation strategies for patients with rectal cancer persists,” Paul B. Romesser, MD, ...

SAN FRANCISCO -- Neoadjuvant chemoradiotherapy with or without the investigational PD-1 inhibitor sintilimab significantly increased pathological complete response (pCR) rates compared with ...

An early-phase, dose-escalation study of a hypofractionated approach to concurrent chemoradiation using an an adaptive stereotactic ablative radiotherapy (SABR) boost showed promising results in ...

HealthDay News — In a practice guideline issued by the American Society for Radiation Oncology and published online November 17 in Practical Radiation Oncology, recommendations are presented for the ...

The incidence of oesophageal adenocarcinoma has had the most rapid rise of any solid tumour malignancy in the United States (Devesa et al, 1998). Over 14 550 Americans were diagnosed with this ...

SYDNEY — There was no clinical benefit from adding cetuximab (Erbitux) to chemoradiation in patients with unresectable stage III non-small cell lung cancer (NSCLC) in the RTOG 0617 trial, and there ...

We performed a retrospective study of 90 consecutive cases with inoperable carcinoma of the oesophagus treated with definitive chemoradiation at a single cancer centre between 1995 and 2002. For the ...